OMCL — Omnicell Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapContrarian

Annual balance sheet for Omnicell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	127	496	360	342	490
Net Total Accounts Receivable
Net Total Receivables	218	190	241	299	252
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	483	829	781	882	928
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	110	114	120	132	134
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	1,241	1,825	2,142	2,211	2,227
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	237	276	876	428	368
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	396	857	996	1,081	1,038
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	845	968	1,147	1,130	1,189
Total Liabilities & Shareholders' Equity	1,241	1,825	2,142	2,211	2,227
Total Common Shares Outstanding